Please use this identifier to cite or link to this item:
Title: Care needed in interpretation of cancer survival measures.
Authors: Rutherford, Mark J.
First Published: 3-Dec-2014
Publisher: Elsevier
Citation: Lancet, 2015, 385 (9974), pp. 1162-1163
Abstract: [First paragraph] Cancer patient survival obtained from population-based cancer studies is the optimum method to monitor and assess the effectiveness of patient care.1 Consideration of these estimates in conjunction with estimates of cancer incidence and mortality is still important.2 As a result, there is much interest in the assessment of progress in terms of cancer survival.3 and 4 Quantification of the improvements in cancer patient survival because of successes in some areas, such as treatment, diagnostic techniques, and awareness or screening campaigns, is of paramount importance to health-care officials, health policy makers, and charities supporting these developments in cancer control. However, to make a fair comparison—to compare like with like—is essential to assess progress accurately.
DOI Link: 10.1016/S0140-6736(14)62292-3
ISSN: 0140-6736
eISSN: 1474-547X
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © Rutherford et al. Open Access article distributed under the terms of CC BY.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
1-s2.0-S0140673614622923-main.pdfPublished (publisher PDF)120.31 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.